[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.148.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 1983

Hemodynamic Effects of VasopressinCan Large Doses Be Safely Given?

Author Affiliations

From the Surgical Service, Audie L. Murphy Memorial Veteran's Hospital (Drs Levine and Gaskill), and the Department of Surgery, University of Texas Health Science Center (Dr Sirinek), San Antonio.

Arch Surg. 1983;118(4):434-437. doi:10.1001/archsurg.1983.01390040046009
Abstract

• We evaluated the effects of intravenous (IV) vasopressin on central hemodynamics, as well as myocardial and gastrointestinal (GI) blood flow, to delineate an optimal dosage balanced to yield maximum reduction of GI blood flow with minimal adverse cardiac effects. Eight miniature swine were anesthetized, ventilated, catheterized, and infused with vasopressin for three consecutive 30-minute periods at logarithmically increasing doses (0.001, 0.01, and 0.1 units/kg/min). We determined cardiac output, systemic arterial pressure, and microsphere tissue blood flow after each infusion. We found that IV vasopressin (0.001 units/kg/min) produced substantial reductions in blood flow to the GI tract and heart, and reduced the cardiac index (3.0±0.4 to 2.1 ±0.3 L/sq m/min). Increased doses of vasopressin (×10 and × 100) decreased gastric mucosal blood flow even more, with minimal adverse effects on cardiac output and myocardial blood flow.

(Arch Surg 1983;118:434-437)

×